- RESEARCH AREAS
- Education and Child Policy
- Energy and Environment
- Finance, Banking
& Monetary Policy - Foreign Policy
and National Security - Government and Politics
- Health, Welfare, and
Entitlements - International Economics
and Development - Law and Civil Liberties
- Political Philosophy
- Regulatory Studies
- Tax and Budget Policy
- Telecom, Internet and
Information Policy - Trade and Immigration
Cato on Facebook
Cato on Twitter
Cato on YouTube
Cato RSS1000 Massachusetts Ave, NW
Washington, DC 20001-5403
Phone (202) 842 0200
Fax (202) 842 3490
Contact Us
FDA and Drug Regulation
Cato Studies
"Avoiding Medicare's Pharmaceutical Trap," by Doug Bandow, Policy Analysis no. 556, November 30, 2005
"Treating Doctors as Drug Dealers: The DEA's War on Prescription Painkillers," by Ronald T. Libby, Policy Analysis no. 545, June 6, 2005
"Health Care Regulation: A $169 Billion Hidden Tax," by Christopher J. Conover, Policy Analysis no. 527, October 4, 2004
"Drug Reimportation: The Free Market Solution," by Roger Pilon, Policy Analysis no. 521, August 4, 2004
"Demonizing Drugmakers: The Political Assault on the Pharmaceutical Industry," by Doug Bandow, Policy Analysis no. 475, May 8, 2003
"How FDA Regulation and Injury Litigation: Cripple the Medical Device Industry," by Charles Homsy, Policy Analysis no. 412, August 28, 2001
"Replace FDA Regulation of Medical Devices with Third-Party Certification," by Noel D. Campbell, Policy Analysis no. 288, November 12, 1997
"Wrecking Ball: FDA Regulation of Medical Devices," by Robert Higgs, Policy Analysis no. 235, August 7, 1995
"Compassion vs Control: FDA Investigational-Drug Regulation," by Dale H. Gieringer, Policy Analysis no. 72, May 20, 1986
Feeds for Cato events: